Combinatorial therapy allows viruses to destroy tumors
March 31, 2010 by admin · Leave a Comment
Contact: Karen Honey
press_releases@the-jci.org
734-546-5242
Journal of Clinical Investigation
For several years, researchers have been developing a new approach to treating cancer that uses viruses to infect and kill cancer cells while leaving normal cells unharmed. Recent data have indicated that this approach, which is known as oncolytic virotherapy, has potential. Now, Richard Vile and colleagues, at the Mayo Clinic, Rochester, have found that this approach can be combined with a standard clinical therapy to provide substantial regression and cure of tumors in mice, leading them to suggest that this combinatorial approach could be of tremendous benefit in the clinic.
Powerful HIV drugs inhibit retrovirus linked to prostate cancer, chronic fatigue syndrome
March 31, 2010 by admin · Leave a Comment
Contact: Phil Sahm
phil.sahm@hsc.utah.edu
801-581-2517
University of Utah Health Sciences Read more
Aging gene governs lifespan, immunity and resilience
Contact: Nancy Mendoza
press.office@bbsrc.ac.uk
44-017-934-13355
Biotechnology and Biological Sciences Research Council
Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) at the University of Birmingham have discovered that a gene called DAF-16 is strongly involved in determining the rate of ageing and average lifespan of the laboratory worm Caenorhabditis elegans (C. elegans) and its close evolutionary cousins. DAF-16 is found in many other animals, including humans. It is possible that this knowledge could open up new avenues for altering ageing, immunity and resistance to stresses in humans. The research is published today (01 April) in PLoS ONE.
A drug that extends life span prevents Alzheimer’s deficits
March 31, 2010 by admin · Leave a Comment
Contact: Will Sansom
sansom@uthscsa.edu
210-567-2579
University of Texas Health Science Center at San Antonio Read more
Mapping heart disease
March 31, 2010 by admin · Leave a Comment
Contact: Josh Baxt
jbaxt@sanfordburnham.org
858-795-5236
Sanford-Burnham Medical Research Institute Read more
Treatment resistance in some cancer cells may be reversible
March 31, 2010 by admin · Leave a Comment
Contact: Katie Marquedant
kmarquedant@partners.org
617-726-0337
Massachusetts General Hospital Read more
Tumor cells seek temporary shelter from cancer drugs
March 31, 2010 by admin · Leave a Comment
Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press
Results reported in the April 2nd issue of the journal Cell, a Cell Press publication, reveal a new source for the drug resistance that crops up all too often and quickly in the tumors of cancer patients undergoing therapy. First the bad news: all cancer cells might have the capacity to enter a drug-tolerant state. But there’s some potentially very good news too: in some cases there may be a way to reverse or block cancer’s drug resistance.
Study shows partial lung removal favorable over full removal as treatment for lung cancer
March 31, 2010 by admin · Leave a Comment
Contact: Megan Richter
mrichter@spectrumscience.com
202-587-2556
International Association for the Study of Lung Cancer Read more
Next decade offers promise for treatment of spinal cord injuries
Contact: Lauren Pearson
pearson@aaos.org
847-384-4031
American Academy of Orthopaedic Surgeons Read more
Acupuncture may be an effective treatment for post-viral infection loss of smell
Contact: Jessica Mikulski
newsroom@entnet.org
703-535-3762
American Academy of Otolaryngology — Head and Neck Surgery
